The EMA warns of products being sold as dendritic cell therapies with little evidence, but high health risks, in the European ...

AstraZeneca’s senior director in oncology data science outlined how the company uses AI for drug discovery at a recent talk.

Boehringer Ingelheim and Sweden-based Salipro Biotech have entered a research and licence agreement for drug targets' ...

Halo Pharmaceutical is a privately owned full service FDA, BLA and DEA (Schedule II-V) compliant CDMO, headquartered in ...

The venture aims to advance MeiraGTx’s Parkinson’s gene therapy through Phase III trials with up to $430m in funding from ...

The EC has approved Otsuka Pharmaceutical and Lundbeck’s atypical oral antipsychotic, Rxulti (brexpiprazole), for treating ...

Insilico Medicine has completed a Series E round, raising $110m to progress the development of its pipeline of drugs and AI ...

NICE estimates that 1,000 women could benefit from Ryeqo, which can be taken once-daily up until the menopause.

The two companies are merging after previously filing for bankruptcy due to opioid-related litigation and financial losses.

A day after announcing a business split-off to focus on weight loss and diabetes implants, Vivani Medical has implanted the ...

Emergent has entered a strategic financial investment agreement with Swiss Rockets to support the latter’s biotech portfolio.

Upperton Pharma Solutions offers services for the development of oral, nasal and pulmonary dosage forms. In this webinar, Dr Richard Johnson goes through the company’s process of developing the ...